Evaluation of the Drug-drug Interaction Between FosD and Verapamil When Taken Together in Healthy Volunteers

Completed · Phase 1

Conditions studied: Drug Drug Interactions, Healthy Volunteers

In brief

This Study evaluates the possible drug interaction between FosD and verapamil when taken together.

Key facts

Study ID

NCT01197781

Run by

AstraZeneca

People needed

15

Starts

2010-09-01

Expected to finish

2010-10-01

Last updated by the study team

2010-11-23

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Weight of at least 50 kg (110 lbs) and body mass index (BMI) between 18 and 35 kg/m2, inclusive.
• Females must be of non-childbearing potential

You may not qualify if…

• History of clinically significant disease or disorder or presence of GI, hepatic or renal disease
• Any clinically significant illness, medical/surgical procedure or trauma within 4 weeks of the first administration of the drug
• Any clinically significant abnormalities in lab safety tests or vital signs as results as judged by the Investigator
• Use of prescription or over-the-counter drugs within 2 weeks of first administration of investigational product
• Current smokers or use of nicotine products within 1 month prior to enrollment

Where it is running

• Recruiting Site — Overland Park, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.